Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS

Abstract Cancer therapy, due to the rising number of detected and reported cases, is one of the most important goals of scientists worldwide. Among these, there is a strong interest in using effective noninvasive protocols for cancer therapy. This study aims to investigate the combined effect of phe...

Full description

Saved in:
Bibliographic Details
Main Authors: HomaSadat Esfahani, Reza Hosseinzadeh, Khatereh Khorsandi
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-05784-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402574274297856
author HomaSadat Esfahani
Reza Hosseinzadeh
Khatereh Khorsandi
author_facet HomaSadat Esfahani
Reza Hosseinzadeh
Khatereh Khorsandi
author_sort HomaSadat Esfahani
collection DOAJ
description Abstract Cancer therapy, due to the rising number of detected and reported cases, is one of the most important goals of scientists worldwide. Among these, there is a strong interest in using effective noninvasive protocols for cancer therapy. This study aims to investigate the combined effect of phenytoin, a sodium channel-blocker, with Methylene Blue, a photosensitizer used in photodynamic therapy (PDT), on breast cancer cell viability and uptake. To determine the appropriate concentrations of phenytoin in Methylene Blue solutions, we measured the intensity of the samples at excitation wavelengths between 200 and 800 nm using a spectrophotometer. Breast cancer cell viability was evaluated in four research groups using the MTT assay under both light and dark conditions. Morphological characterization was performed using an inverted light microscope and dual acridine orange/ethidium bromide (AO/EB) fluorescent staining. The hypothesis focuses on the effect of pre-treatment with phenytoin on cellular uptake of Methylene Blue and the impact on cell viability. These effects were examined across four distinct treatment groups to comprehensively assess the potential benefits of combined treatment. The results showed that the combination treatment not only increased cellular uptake but also demonstrated higher toxicity to cancer cells, suggesting enhanced therapeutic potential. Additionally, the study highlights the importance of noninvasive protocols in cancer therapy, paving the way for further research into optimizing such treatments.
format Article
id doaj-art-c0e8f9a1c6a04abfa5e553a8900946f3
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-c0e8f9a1c6a04abfa5e553a8900946f32025-08-20T03:37:30ZengNature PortfolioScientific Reports2045-23222025-07-011511910.1038/s41598-025-05784-6Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PSHomaSadat Esfahani0Reza Hosseinzadeh1Khatereh Khorsandi2Department of Photodynamic, Medical Laser Research Center, Yara Institute, ACECRDepartment of Photodynamic, Medical Laser Research Center, Yara Institute, ACECRDepartment of Photodynamic, Medical Laser Research Center, Yara Institute, ACECRAbstract Cancer therapy, due to the rising number of detected and reported cases, is one of the most important goals of scientists worldwide. Among these, there is a strong interest in using effective noninvasive protocols for cancer therapy. This study aims to investigate the combined effect of phenytoin, a sodium channel-blocker, with Methylene Blue, a photosensitizer used in photodynamic therapy (PDT), on breast cancer cell viability and uptake. To determine the appropriate concentrations of phenytoin in Methylene Blue solutions, we measured the intensity of the samples at excitation wavelengths between 200 and 800 nm using a spectrophotometer. Breast cancer cell viability was evaluated in four research groups using the MTT assay under both light and dark conditions. Morphological characterization was performed using an inverted light microscope and dual acridine orange/ethidium bromide (AO/EB) fluorescent staining. The hypothesis focuses on the effect of pre-treatment with phenytoin on cellular uptake of Methylene Blue and the impact on cell viability. These effects were examined across four distinct treatment groups to comprehensively assess the potential benefits of combined treatment. The results showed that the combination treatment not only increased cellular uptake but also demonstrated higher toxicity to cancer cells, suggesting enhanced therapeutic potential. Additionally, the study highlights the importance of noninvasive protocols in cancer therapy, paving the way for further research into optimizing such treatments.https://doi.org/10.1038/s41598-025-05784-6Combination drug effectIonic photosensitizerCancer therapyChannel-blockersMethylene bluePhenytoin sodium
spellingShingle HomaSadat Esfahani
Reza Hosseinzadeh
Khatereh Khorsandi
Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS
Scientific Reports
Combination drug effect
Ionic photosensitizer
Cancer therapy
Channel-blockers
Methylene blue
Phenytoin sodium
title Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS
title_full Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS
title_fullStr Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS
title_full_unstemmed Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS
title_short Investigation on the phenytoin sodium channel-blocker effect in PDT of MDA MB 231 breast cancer using a positively charged PS
title_sort investigation on the phenytoin sodium channel blocker effect in pdt of mda mb 231 breast cancer using a positively charged ps
topic Combination drug effect
Ionic photosensitizer
Cancer therapy
Channel-blockers
Methylene blue
Phenytoin sodium
url https://doi.org/10.1038/s41598-025-05784-6
work_keys_str_mv AT homasadatesfahani investigationonthephenytoinsodiumchannelblockereffectinpdtofmdamb231breastcancerusingapositivelychargedps
AT rezahosseinzadeh investigationonthephenytoinsodiumchannelblockereffectinpdtofmdamb231breastcancerusingapositivelychargedps
AT khaterehkhorsandi investigationonthephenytoinsodiumchannelblockereffectinpdtofmdamb231breastcancerusingapositivelychargedps